Narcolepsy With Cataplexy Nt1 clinical trials

Explore recruiting narcolepsy with cataplexy nt1 clinical trials.

Recruiting narcolepsy with cataplexy nt1 studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Narcolepsy With Cataplexy Nt1 trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Safety, Tolerability, and Efficacy of TAK-360 for the Treatment of Narcolepsy with Cataplexy (Narcolepsy Type 1)

Spain, Italy, France

Therapeutic exploratory (Phase II) EU CTIS Study details

Narcolepsy With Cataplexy Nt1 trials by city

Narcolepsy With Cataplexy Nt1 in Toronto Narcolepsy With Cataplexy Nt1 in Vancouver Narcolepsy With Cataplexy Nt1 in Montreal Narcolepsy With Cataplexy Nt1 in Calgary Narcolepsy With Cataplexy Nt1 in Edmonton Narcolepsy With Cataplexy Nt1 in Ottawa Narcolepsy With Cataplexy Nt1 in Winnipeg Narcolepsy With Cataplexy Nt1 in Quebec City Narcolepsy With Cataplexy Nt1 in Hamilton Narcolepsy With Cataplexy Nt1 in Kitchener Narcolepsy With Cataplexy Nt1 in London Narcolepsy With Cataplexy Nt1 in Halifax Narcolepsy With Cataplexy Nt1 in New York Narcolepsy With Cataplexy Nt1 in Los Angeles Narcolepsy With Cataplexy Nt1 in Chicago Narcolepsy With Cataplexy Nt1 in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease